DHL Supply Chain has been awarded a warehousing and distribution contract by medical technology company Becton Dickinson for select sites in India.

According to DHL, the project is being implemented, with major sites already having gone live and the rest scheduled for completion by mid-2019. Among them is a new temperature-controlled facility which has been inaugurated in Luhari, Haryana. DHL Supply Chain has also obtained ISO 13485 certification for each site, ensuring that the quality of medical device provision complies with recognized global standards.

“We are delighted to be awarded the contract to handle BD’s warehousing and distribution in India,” said Terry Ryan, CEO of DHL Supply Chain Asia Pacific. “According to the India Brand Equity Foundation, the life sciences and healthcare industry in India is growing rapidly, with an expected compound annual growth rate of over 16% from now to the year 2022. This makes the healthcare sector a focus area for DHL Supply Chain – especially in India, which has a 2.8% share of the global biopharmaceutical market. Being entrusted to consolidate and manage BD’s supply chain in a country of this size and complexity demonstrates the strength of DHL Supply Chain’s core expertise in optimizing warehouse operations, enhancing transportation solutions and standardizing work processes.”

DHL Supply Chain is in full compliance with all domestic regulatory requirements and has also standardized operational quality and systems across all sites, while improving visibility in local transportation.

“BD is continuously looking at ways to serve our customers and patients better,” said Pavan Mocherla, managing director of India and South Asia at BD. “This journey with DHL Supply Chain is one such initiative; improving our ability to reach different geographies and in ways that delight our customers, enabling us in advancing the world of health.”